Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 1
2003 1
2004 3
2005 2
2006 3
2007 3
2008 7
2009 13
2010 17
2011 20
2012 37
2013 59
2014 54
2015 57
2016 82
2017 85
2018 92
2019 114
2020 108
2021 145
2022 151
2023 140
2024 170
2025 63

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,235 results

Results by year

Filters applied: . Clear all
Page 1
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
Cardones AR. Cardones AR. Clin Dermatol. 2020 Nov-Dec;38(6):702-711. doi: 10.1016/j.clindermatol.2020.06.008. Epub 2020 Jun 27. Clin Dermatol. 2020. PMID: 33341203 Review.
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe cutaneous drug reaction characterized by fever, lymphadenopathy, hematologic abnormalities, multisystem involvement, and viral reactivation. ...
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe cutaneou
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.
Wei BM, Fox LP, Kaffenberger BH, Korman AM, Micheletti RG, Mostaghimi A, Noe MH, Rosenbach M, Shinkai K, Kwah JH, Phillips EJ, Bolognia JL, Damsky W, Nelson CA. Wei BM, et al. J Am Acad Dermatol. 2024 May;90(5):885-908. doi: 10.1016/j.jaad.2023.02.072. Epub 2023 Jul 27. J Am Acad Dermatol. 2024. PMID: 37516359 Review.
Drug-induced hypersensitivity syndrome (DiHS), also known as drug reaction with eosinophilia and systemic symptoms (DRESS), is a severe cutaneous adverse reaction (SCAR) characterized by an exanthem, fever, and hematologic and visc …
Drug-induced hypersensitivity syndrome (DiHS), also known as drug reaction with eosinophilia and syste
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management.
Wei BM, Fox LP, Kaffenberger BH, Korman AM, Micheletti RG, Mostaghimi A, Noe MH, Rosenbach M, Shinkai K, Kwah JH, Phillips EJ, Bolognia JL, Damsky W, Nelson CA. Wei BM, et al. J Am Acad Dermatol. 2024 May;90(5):911-926. doi: 10.1016/j.jaad.2023.02.073. Epub 2023 Jul 28. J Am Acad Dermatol. 2024. PMID: 37516356 Review.
Drug-induced hypersensitivity syndrome, also known as drug reaction with eosinophilia and systemic symptoms, is a severe cutaneous adverse reaction characterized by an exanthem, fever, and hematologic and visceral organ involvement …
Drug-induced hypersensitivity syndrome, also known as drug reaction with eosinophilia and systemic
Drug Reaction with Eosinophilia and Systemic Symptoms.
Kroshinsky D, Cardones ARG, Blumenthal KG. Kroshinsky D, et al. N Engl J Med. 2024 Dec 12;391(23):2242-2254. doi: 10.1056/NEJMra2204547. N Engl J Med. 2024. PMID: 39665653 Review. No abstract available.
Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019.
Shiohara T, Mizukawa Y. Shiohara T, et al. Allergol Int. 2019 Jul;68(3):301-308. doi: 10.1016/j.alit.2019.03.006. Epub 2019 Apr 16. Allergol Int. 2019. PMID: 31000444 Free article. Review.
The aim of this review was to provide an updated overview of drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS). Several new insights have been made, particularly with regard …
The aim of this review was to provide an updated overview of drug-induced hypersensitivity syndrome (DiHS)/drug reaction wi
Drug reaction with eosinophilia and systemic symptoms: An emergency medicine focused review.
Gottlieb M, Figlewicz MR, Rabah W, Buddan D, Long B. Gottlieb M, et al. Am J Emerg Med. 2022 Jun;56:1-6. doi: 10.1016/j.ajem.2022.03.024. Epub 2022 Mar 18. Am J Emerg Med. 2022. PMID: 35338896 Review.
INTRODUCTION: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe drug reaction associated with potentially severe morbidity and mortality. ...
INTRODUCTION: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe dru …
Drug reaction with eosinophilia and systemic symptoms (DRESS) in children.
Mori F, Caffarelli C, Caimmi S, Bottau P, Liotti L, Franceschini F, Cardinale F, Bernardini R, Crisafulli G, Saretta F, Novembre E. Mori F, et al. Acta Biomed. 2019 Jan 29;90(3-S):66-79. doi: 10.23750/abm.v90i3-S.8167. Acta Biomed. 2019. PMID: 30830064 Free PMC article. Review.
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) is a severe reaction to drugs. ...
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) is a severe reaction to drugs
Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)-Readdressing the DReSS.
Stirton H, Shear NH, Dodiuk-Gad RP. Stirton H, et al. Biomedicines. 2022 Apr 26;10(5):999. doi: 10.3390/biomedicines10050999. Biomedicines. 2022. PMID: 35625735 Free PMC article. Review.
Drug reaction with eosinophilia and systemic symptoms (DReSS), also known as drug-induced hypersensitivity syndrome (DiHS), is a severe, systemic, T cell mediated drug reaction with combinations of cutaneous, hematologic, and inter
Drug reaction with eosinophilia and systemic symptoms (DReSS), also known as drug-induced h
Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS): How Far Have We Come?
Martínez-Cabriales SA, Rodríguez-Bolaños F, Shear NH. Martínez-Cabriales SA, et al. Am J Clin Dermatol. 2019 Apr;20(2):217-236. doi: 10.1007/s40257-018-00416-4. Am J Clin Dermatol. 2019. PMID: 30652265 Review.
Drug reaction with eosinophilia and systemic symptoms (DReSS), also known as drug-induced hypersensitivity syndrome (DiHS), is an uncommon severe adverse reaction to medications. ...
Drug reaction with eosinophilia and systemic symptoms (DReSS), also known as drug-induced h
Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study.
Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, Sidoroff A, Naldi L, Mockenhaupt M, Roujeau JC; RegiSCAR study group. Kardaun SH, et al. Br J Dermatol. 2013 Nov;169(5):1071-80. doi: 10.1111/bjd.12501. Br J Dermatol. 2013. PMID: 23855313
BACKGROUND: Cases of severe drug hypersensitivity, demonstrating a variable spectrum of cutaneous and systemic involvement, are reported under various names, especially drug reaction with eosinophilia and systemic symptoms (DRESS). …
BACKGROUND: Cases of severe drug hypersensitivity, demonstrating a variable spectrum of cutaneous and systemic involvement, are reported und …
1,235 results